baber/WOPTO huggingface dataset:
Patent DE-69122924-T2 (DE)
Inventor: BONNAFOUX JEAN-FRANCOIS
IPC: G06F15/16
Filed: 1991-07-24
Granted: 1997-03-06
Abstract: The present invention relates to an architecture for service processor dynamic swapping. Architecture for service processor dynamic swapping, comprising a first service processor linked by a network and a maintenance unit (CMU) to a central system (4), the said service processor (1) being linked to a second service processor (2) by the network and the maintenance unit (CMU), characterised in that each service processor in addition comprises exploitation system programs, a supervisory program and at least one service broken down into two applications, one "body" composed of the algorithm of the program, the other "presentation" comprising the interface with the operator permitting display of the window type with a menu caption, and MSH means (10, 20) of communications processing with the other service processors, via the maintenance unit (CMU), a supervisory program managing the priority numbers of the services and initiating the services, the said supervisory program having access to a configuration table for the system (IRT, ECF). <IMAGE>
Patent DE-69123500-T2 (DE)
Inventor: ORDENTLICH ERIK
IPC: G10L19/14
Filed: 1991-06-20
Granted: 1997-04-17
Abstract: An improved digital communication system, e.g., a CELP code/decoder based system, is improved for use with a wide-band signal such as a high-quality speech signal by modifying the noise weighting filter used in such systems to include a filter section which affects primarily the spectral tilt of the weighting filter in addition to a filter component reflecting formant frequency information in the input signal. Alternatively, the weighting is modified to reflect perceptual transform techniques. <IMAGE>
Patent DE-69126335-T2 (DE)
Inventor: KELLENBERGER STANLEY ROY
IPC: A61F13/15
Filed: 1991-02-25
Granted: 1998-01-15
Abstract: An absorbent structure and garment comprises a superabsorbent material having a free-swell rate of less than about 60 seconds and a five-minute AUL of at least 15 g/g. The superabsorbent material is contained by containment means, such as a fibrous matrix, such that the superabsorbent material is present in said absorbent structure in an amount of from about 60 to about 100 weight percent based on the total weight of the containment means and superabsorbent material. The containment means may contain a high concentration of a superabsorbent material and define a dry volume less than about 180 cubic centimeters. The absorbent garment has a saturated retention capacity of at least about two times the dry volume, wherein the containment means and superabsorbent material account for at least about 60 volume percent of said saturated retention capacity. <IMAGE>
Patent DE-69129901-T2 (DE)
Inventor: PRICE ELVIN
IPC: D05B65/00
Filed: 1991-12-19
Granted: 1998-12-17
Abstract: An apparatus and method for creating an overlock or 504 stitch wherein the excess thread chain (65) extending from the sewing machine needles (19) and the hollow chaining (32) to the previously sewn garment part (60) is stretched and is cut by thread chain cutter (70) to create a leading thread chain of predetermined length extending form the sewing machine needle and the hollow chaining tongue. When cut, the thread chain recoils toward the hollow chaining tongue, and a stream of air draws the free end of the thread chain into the hollow chaining tongue. When the next work piece is moved through the sewing area, the thread chain in the hollow chaining tongue is attached to the work piece and is progressively drawn out of the hollow chaining tongue and oversewn in the overlock stitch.
Patent DE-69208503-T2 (DE)
Inventor: LAHMANI PAUL
IPC: A61K8/49
Filed: 1992-04-14
Granted: 1996-09-19
Abstract: The subject of the invention is microcapsules comprising one or more sunscreen products characterised in that the said microcapsules are hardened so as to make them imperveous.
Patent DE-69215266-T2 (DE)
Inventor: VAN GYSEL AUGUST
IPC: C07D235/18
Filed: 1992-03-30
Granted: 1997-05-28
Abstract: Process for the preparation of 1H-benzimidazoles substituted in position 2, preferably those corresponding to the general formula <IMAGE>  in which   R1 represents a linear or branched alkyl containing 1 to 13 carbon atoms, a phenyl, halophenyl, 4-nitrophenyl, 4-methylphenyl, 4-cyanophenyl, 4-carboxyphenyl, benzyl, thienyl, furanyl, pyridyl, or 1,3- or 1,4-phenylene, R2 represents a hydrogen or chlorine atom, nitro or carboxyl, 2-(4-chlorophenyl)-1H-benzimidazol-5-yl, or 2-(4-carboxyphenyl)- 1H-benzimidazol-5-yl, and   n is equal to 1 or 2.   According to the invention, an aldehyde, a thionyl halide and a nitrogen-containing aromatic heterocyclic compound are reacted together, the product formed is then reacted with an optionally substituted 1,2-benzenediamine and the 1H-benzimidazole thus obtained is separated from the reaction mixture. Using this process, 1H-benzimidazoles are obtained in a single stage, under moderate conditions, with very high yields.
Patent DE-69225489-T2 (DE)
Inventor: VALERIO DOMENICO
IPC: A61K48/00
Filed: 1992-10-05
Granted: 1999-01-07
Abstract: A method is provided for genetically modifying primate bone marrow cells, comprising isolating bone marrow cells from a primate and, by means which enhance the local concentration of retroviral particles, contacting the isolated bone marrow cells to cells that produce a recombinant amphotropic retrovirus with a genome based on a retroviral vector that contains the genetic information to be introduced into the bone marrow cells. Recombinant amphotropic retrovirus-producing cells, suitable for use in this method also are provided, as are genetically modified primate bone marrow cells with the capacity for regeneration in vivo.
Patent DE-69311121-T2 (DE)
Inventor: KLING ROBERT
IPC: A61F5/44
Filed: 1993-09-14
Granted: 1997-11-13
Abstract: PCT No. PCT/SE93/00744 Sec. 371 Date Mar. 15, 1995 Sec. 102(e) Date Mar. 15, 1995 PCT Filed Sep. 14, 1993 PCT Pub. No. WO94/06384 PCT Pub. Date Mar. 31, 1994A method and an arrangement for mounting elastic elements (T) on an elongated, moving material web (M), in which an elastic element extends between two holder elements (H) which are moved in a given direction and which elastic element extends essentially at right angles to the movement direction of the holder elements. According to the invention, different points on an elastic element which are mutually displaced transversely in relation to the movement direction are moved at mutually different speeds in relation to one another, and the elastic element is fastened to the material web subsequent to having achieved given distances in the movement direction between the different points on the elastic element, as a result of the different movement speeds.
Patent DE-69313720-T2 (DE)
Inventor: DEMISSY DANIEL
IPC: H01H31/28
Filed: 1993-05-07
Granted: 1998-01-08
Abstract: High-voltage isolator of the type comprising a female current socket placed at one end of a first vertical insulating column (2), an operating blade (13) articulated to one end of a second vertical insulating column (7) and carrying at a first end a male contact (13B) intended to cooperate with the said female contact, the movement of the blade being ensured by a mechanism connected to an oscillating insulating column (20), characterised in that the articulation of the said blade (13) to the said second column (7) is ensured by means of two levers (12, 14) of unequal length. <IMAGE>
Patent DE-69319312-T2 (DE)
Inventor: RICKWOOD MARTIN
IPC: C08L29/04
Filed: 1993-11-25
Granted: 1998-12-17
Abstract: A photo reactive material, such as a photochromic material, which has the following structure: <CHEM>  where   A   is a six membered carbocyclic or heterocyclic ring; each R   is alkyl, alkenyl, alkynyl, aryl,  carbocyclic, heterocyclic, alkyl carbocyclic or alkyl heterocyclic or at least two of the R groups together form part of a carbocyclic or heterocyclic ring or one of the R groups is hydrogen with the other two being selected from the above; R*   are independent of one another and are selected from branched or linear C1-C10 alkyls and carbocyclic or heterocyclic groups or both form part of a carbocyclic or heterocyclic ring; R<+>m   is selected from alkyl alkoxy, amino, halogen, cyano, nitro, trifluoromethyl or aryl and m has a value between 0 and 4; R<+>n   is selected from carbocyclic and heterocyclic groups which are fused to A and n has a value between 0 and 2. R'   is selected from hydrogen, alkyl, alkoxy, amino, carbocylic or heterocyclic. R''   is selected from hydrogen, alkyl, aryl, heteroaryl, alkenyl, alkynyl, alkoxy, aryloxy, amino, halogen, cyano, nitro, trifluoromethyl, imino, azo, carboxy ester or amide or is a carbocyclic or heterocyclic group fused to the moiety.
Patent DE-69328075-T2 (DE)
Inventor: YASUDA TAKAO
IPC: B60T11/16
Filed: 1993-12-21
Granted: 2000-10-05
Abstract: A control valve assembly for a total pressure hydraulic brake is provided with an input port, an output port, a remote control input port connected to a hydraulic fluid supply means, a first response member which is moved together with depression of a brake pedal, a second response member which is moved by the hydraulic fluid flowing through the remote control input port, and control means which operates in accordance with the movement of either the first or the second response member. The control valve supplies the hydraulic fluid from the input port to the output port in response to the hydraulic fluid flowing through the remote control input port, as well as the depressing force exerted on the brake pedal. <IMAGE>
Patent DE-69328128-T2 (DE)
Inventor: NAKAGAMI HIROAKI
IPC: A61K9/16
Filed: 1993-10-27
Granted: 2000-08-24
Abstract: A granular pharmaceutical preparation prepared by granulating finely powdered Ebselen(2-phenyl-1,2-benzisoselenazol-3(2H)-one) using a hydrophilic polymer, and an aqueous suspension thereof. The Ebselen granular pharmaceutical preparation of the present invention is excellent in its performance as an oral preparation for use in stomach tube administration. That is, since it can be dispersed easily and uniformly when suspended in water or an aqueous solution before its use, and the suspension can be maintained in excellent dispersed state, preparation and tube administration of the drug solution can be made easily. Also, its dose is accurate because the administration can be effected with no drug or drug solution remained in the tube after the administration. In addition, the granular pharmaceutical preparation of the present invention is also suited for its large scale production, because it can be produced without employing special apparatuses and production steps.
Patent DE-69413952-T2 (DE)
Inventor: CAPIAU CARINE
IPC: C12N1/02
Filed: 1994-02-28
Granted: 1999-05-12
Abstract: PCT No. PCT/EP94/00597 Sec. 371 Date Oct. 23, 1995 Sec. 102(e) Date Oct. 23, 1995 PCT Filed Feb. 28, 1994 PCT Pub. No. WO94/20538 PCT Pub. Date Sep. 15, 1994The present invention discloses a process for extracting a cell-bound protein of bacterial origin, useful in acellular vaccines, comprising contacting a suspension of the cell-bound protein with a flocculating agent prior to heat treatment.
Patent DE-69423391-T2 (DE)
Inventor: KASISKE JOHN M
IPC: C22C38/52
Filed: 1994-06-24
Granted: 2000-07-06
Abstract: An austenitic iron-based alloy contains 38 to 62% by wt. in total of alloying elements, the balance being iron. The alloying elements consist of, by wt., 0.02-0.80% C, 20-30% Cr, 7-9% Ni, 5-9% Mo, 3-9% Co, and 0.5-3% Mn. Preferably, the alloy contains 42 to 44% of alloying elements in total, the individual elements each lying within the ranges set out above. An alloy contg. 0.047% C, 1.18% Mn, 2.76% Si, 21.18% Cr, 8.23% Mo, 8.98% Ni, and 5.16% Co was deposited by submerged arc welding, after which it had a smooth crack-free surface and hardness of Rc 46 at 1/16 inch below the surface. Friction coefft. was 0.373, while that for Stellite 1 was 0.518 and for Stellite 6 was 0.770. Hot hardness at 800 deg.F, 1200 deg.F and 1600 deg.F was (DPH scale) 413, 359, and 140, respectively. Corresp. values for Stellite 1 were 510, 390, and 187, and for Stellite 6 were 300, 260, and 90.
Patent DE-69426335-T2 (DE)
Inventor: ROE CARROLL
IPC: C08L29/04
Filed: 1994-09-30
Granted: 2001-05-23
Abstract: Flexible, porous, absorbent polymeric macrostructures having flexibility even after extended periods at elevated temperatures and/or low humidities are disclosed. The macrostructure comprises an interparticle crosslinked aggregate and an effective amount of a suitable plasticizer. The macrostructures are suitable for use, for example, in disposable absorbent articles such as diapers.
Patent DE-69427989-T2 (DE)
Inventor: WASSERMAN HAROLD
IPC: G01N21/956
Filed: 1994-11-03
Granted: 2002-04-11
Abstract: A printed circuit board inspection system acquires images for purposes of inspection from viewing fields defined along the surface of the printed circuit board to be inspected which can be varied in size to accommodate the density and tolerance of components associated with the printed circuit board under inspection. To this end, the cameras of the inspection head associated with the printed circuit board inspection system are provided with zoom lenses, which are capable of controlled operation responsive to the existing microprocessor systems of the printed circuit board inspection system. This allows the magnification of images acquired by the cameras to be varied, as desired, in turn varying the size of the viewing fields defined for inspection purposes. The inspection head is then operated at a rate commensurate with the size of the viewing fields which have been selected. Such operations can be varied automatically, by the printed circuit board inspection system, to effectively inspect printed circuit boards of different type and configuration. The printed circuit board inspection system can also perform successive inspections of a printed circuit board, at different magnifications.
Patent DE-69430385-T2 (DE)
Inventor: HUFF R
IPC: C07D405/06
Filed: 1994-12-12
Granted: 2002-11-07
Abstract: Compounds of formula    <IMAGE>  (I)  are HIV protease inhibitors. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Patent DE-69500254-T2 (DE)
Inventor: PHILIPPE MICHEL
IPC: A61K8/00
Filed: 1995-03-15
Granted: 1997-07-31
Abstract: New derivs. of serine are of the formula R-O-C(O)-NH-(CH2OH)CH-C(O)-O-R' (I), and/or their D or L optical isomers. R, R' = 8-30C hydrocarbon gps. 12 cpds. are specifically claimed, e.g. dodecyl-3-hydroxy-2-(N-hexadecyloxy-carbonyl) aminopropionate.
Patent DE-69501226-T2 (DE)
Inventor: DEHENNAU CLAUDE
IPC: C08J7/12
Filed: 1995-04-11
Granted: 1998-06-25
Abstract: An article, esp. a film, printed with an ink intended for printing of PVC, has at least a surface region comprising at least one polyolefin that has been treated with oxygen and fluorine and is characterised by the presence in the surface of F and O in concns. such that the atomic ratio O/C measured by ESCA spectroscopy (Electron Spectroscopy for Chemical Analysis) measured at a depth of 1.5 nm is at least 0.00 and the atomic ratio F/C measured in the same way is at least 90% and at most 290% of the O/C ratio.
Patent DE-69504663-T2 (DE)
Inventor: KELDER ERIK M
IPC: C01G53/00
Filed: 1995-06-09
Granted: 1999-02-18
Abstract: PCT No. PCT/DK95/00232 Sec. 371 Date Feb. 14, 1997 Sec. 102(e) Date Feb. 14, 1997 PCT Filed Jun. 9, 1995 PCT Pub. No. WO95/34919 PCT Pub. Date Dec. 21, 1995A process is disclosed for the preparation of lithium secondary battery cathode active materials which are of the form LiyMn2-zM2O4 where M is selected from the group consisting of Co, Ni, Ti, V and Fe, y is in the range from 0 to 1.5 and z is in the range from 0 to 1. The process comprises forming a melt or saturated solution from manganese acetate, lithium hydroxide and water, keeping the melt/solution at a temperature in the range of 70 to 110 DEG  C. for a period of from 10 minutes to 4 hours under stirring so as to form an essentially homogeneous material, and drying said material followed by calcination at a temperature in the range of 300 to 800 DEG  C.
Patent DE-69512774-T2 (DE)
Inventor: NILSEN HEIDI
IPC: G01N21/64
Filed: 1995-08-10
Granted: 2000-03-02
Abstract: The present invention relates to a method for examining the quality or the quality changes of a specimen of material by measuring the intensity of photons emitted by the material, which has been excited by submission to a white light source, in air and in CO2, and correlating the measured intensities and comparing this result with similar measurements of fresh samples. Furthermore, the invention relates to a device for implementing the method, and use of the method for examining the quality of material. <IMAGE>
Patent DE-69519594-T2 (DE)
Inventor: KIRK IAN ALASTAIR
IPC: E21B17/10
Filed: 1995-03-09
Granted: 2001-08-09
Abstract: A casing centraliser (10) includes an annular body (12) and a substantially cylindrical bore (16) extending longitudinally through the body (12). A number of blades (14) extend longitudinally along the body (12) and are circumferentially distributed around the body (12) to define a flow path between each adjacent pair of blades (14). Each flow path provides a fluid flow path between longitudinally opposite ends of the centraliser (10) and each blade (14) has a radially outer edge providing a well bore contacting surface. The cylindrical bore (16) through the body (12) is a clearance fit around casing intended to be centralised by the centraliser (10). The centraliser (10) is typically manufactured from a material which includes a zinc alloy. <IMAGE>
Patent DE-69521054-T2 (DE)
Inventor: DELORME DANIEL
IPC: A61P43/00
Filed: 1995-10-25
Granted: 2001-11-22
Abstract: Compounds having the Formula I:R1R2C(OR3)-Ar1-X-Ar2-Ar3Ire inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
Patent DE-69523864-T2 (DE)
Inventor: SHOJI YASUO
IPC: C07D487/04
Filed: 1995-06-05
Granted: 2002-06-13
Abstract: The invention provides a pyrazoloÄ1,5-aÜpyrimidine derivative of the following formula (1): <CHEM> wherein R<1> is hydrogen, lower alkyl which may have thienyl, lower alkoxy, lower alkylthio, oxo or hydroxyl as a substituent, cycloalkyl, thienyl, furyl, lower alkenyl, or phenyl which may have 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, phenylthio and halogen; R<2> is naphthyl, cycloalkyl, furyl, thienyl, optionally halogen-substituted pyridyl, optionally halogen-substituted phenoxy, or phenyl which may have 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, halogen, nitro, halogen-substituted lower alkyl, halogen-substituted lower alkoxy, lower alkoxycarbonyl, hydroxyl, phenyl(lower)alkoxy, amino, cyano, lower alkanoyloxy, phenyl and di(lower)alkoxyphosphoryl(lower)alkyl; R<3> is hydrogen, phenyl or lower alkyl; R<4> is hydrogen, lower alkyl, lower alkoxycarbonyl, phenyl(lower)alkyl, optionally phenylthio-substituted phenyl, or halogen; R<5> is hydrogen or lower alkyl; R<6> is hydrogen, lower alkyl, phenyl(lower)alkyl, or benzoyl having 1 to 3 substituents selected from the group consisting of lower alkoxy, halogen-substituted lower alkyl and halogen; R<1> and R<5> may conjointly form lower alkylene; Q is carbonyl or sulfonyl; A is a single bond, lower alkylene or lower alkenylene; and n is 0 or 1. This derivative is useful as a potent analgesic.
Patent DE-69525036-T2 (DE)
Inventor: WILDING PETER
IPC: C12Q1/68
Filed: 1995-11-13
Granted: 2002-08-01
Abstract: Disclosed are devices for amplifying a preselected polynucleotide in a sample by conducting a polynucleotide amplification reaction. The devices are provided with a substrate microfabricated to include a polynucleotide amplification reaction chamber, having at least one cross-sectional dimension of about 0.1 to 1000  mu m. The device also includes at least one port in fluid communication with the reaction chamber, for introducing a sample to the chamber, for venting the chamber when necessary, and, optionally, for removing products or waste material from the device. The reaction chamber may be provided with reagents required for amplification of a preselected polynucleotide. The device also may include means for thermally regulating the contents of the reaction chamber, to amplify a preselected polynucleotide. Preferably, the reaction chamber is fabricated with a high surface to volume ratio, to facilitate thermal regulation. The amplification reaction chamber also may be provided with a composition which diminishes inhibition of the amplification reaction by material comprising a wall of the reaction chamber, when such treatment is required.
Patent DE-69525350-T2 (DE)
Inventor: TARPLEE JENNIFER
IPC: D06F58/20
Filed: 1995-12-09
Granted: 2002-08-14
Abstract: A clothes dryer comprises a zeolite adsorption system for improved energy efficiency. The system comprises a closed container (K) of zeolite and water in a vacuum. Heating and cooling effects are obtained due to the adsorption and desorption processes and may be used at various time in the drying cycle. This novel application of adsorption technology requires little space inside the appliance and has a low cost. <IMAGE>
Patent DE-69526241-T2 (DE)
Inventor: MEIER HANS J
IPC: A23L3/34
Filed: 1995-11-06
Granted: 2002-12-12
Abstract: A method of extending the shelf-life of fresh foods, such as meat, poultry, seafood, vegetables and fruit, uses a sheet comprising a film with a layer of adhesive and a curing or marinating agent attached to the film by the adhesive. The food is sealed in the sheet, with the curing or marinating agent in intimate contact with the food, and the package is maintained at a temperature of about 0  DEG C until the food is substantially cured or marinated.
Patent DE-69534960-T2 (DE)
Inventor: MOY DAVID
IPC: B01J37/03
Filed: 1995-05-12
Granted: 2007-03-01
Abstract: A catalyst for the production of carbon fibrils and a method for the manufacture of such a catalyst comprising contacting a fibril-forming catalyst or precursors of a fibril-forming catalyst with an effective amount of a surfactant and/or polyol. The improved carbon fibrils or carbon fibril aggregates produced using the catalyst are free of a continuous carbon thermal overcoat, with graphitic layers substantially parallel to the fibril axis, and have a substantially constant diameter from about 1.0 to 100 nanometers. The improved carbon fibrils possess enhanced dispersion in composite materials and provide enhanced electrical conductivity in those materials.
Patent DE-69603078-T2 (DE)
Inventor: COLBY WILLIAM
IPC: B65D71/00
Filed: 1996-04-24
Granted: 1999-12-23
Abstract: PCT No. PCT/GB96/00981 Sec. 371 Date Mar. 6, 1998 Sec. 102(e) Date Mar. 6, 1998 PCT Filed Apr. 24, 1996 PCT Pub. No. WO96/33924 PCT Pub. Date Oct. 31, 1996A multi-pack comprising a plurality of containers, each having a respective label attached thereto, and packaging for holding said plurality of containers together, wherein the packaging is formed from a strip of sheet material which also constitutes at least part of said labels, and the packaging includes a plurality of connecting portions each of which extends from one to the other of a respective contiguous pair of the containers to join those containers together.